<DOC>
	<DOCNO>NCT02651142</DOCNO>
	<brief_summary>Sentinel lymph node biopsy（SLNB） establish way predict axillary nodal metastasis early breast cancer . We aim determinethe，in prospective randomize , control trial , effect sentinel lymph node biopsy para-sentinel lymph node ( SLN ) dissection versus sentinel lymph node biopsy without para-sentinel lymph node dissection outcome breast surgery .</brief_summary>
	<brief_title>A Randomized , Controlled Trial Sentinel Lymph Node Biopsy With Without Para-Sentinel Lymph Node Dissection Breast Cancer</brief_title>
	<detailed_description>Aim : Compare disease-free survival ( DFS ) overall survival ( OS ) breast cancer patient randomize receive sentinel lymph node biopsy para-sentinel lymph node dissection group vs. receive sentinel lymph node biopsy without para-sentinel lymph node dissection Outline : Patients randomize assign follow one two group follow annually . Arm I : Patients receive sentinel lymph node biopsy para-sentinel lymph node dissection Arm II : Patients receive sentinel lymph node biopsy without para-sentinel lymph node dissection</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>histologically confirm primary breast cancer core needle biopsy excisional biopsy abnormal parasentinel lymph node find ultrasound examination ultrasoundguided fine needle aspiration cytology node perform result fine needle aspiration cytology negative ( tumour cell find ) patient plan perform SLNB pathological diagnose ductal carcinoma situ excisional biopsy result fine needle aspiration cytology positive patient receive neoadjuvant system therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>